BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9230311)

  • 1. Alpha-mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis.
    Chui D; Oh-Eda M; Liao YF; Panneerselvam K; Lal A; Marek KW; Freeze HH; Moremen KW; Fukuda MN; Marth JD
    Cell; 1997 Jul; 90(1):157-67. PubMed ID: 9230311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Golgi alpha-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammals.
    Moremen KW
    Biochim Biophys Acta; 2002 Dec; 1573(3):225-35. PubMed ID: 12417404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
    Fukuda MN
    Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II.
    Fukuda MN; Masri KA; Dell A; Luzzatto L; Moremen KW
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7443-7. PubMed ID: 2217175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test.
    Fukuda MN
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):231-9. PubMed ID: 10571015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomannosides or oligosaccharide-lipids as potential substrates for rat liver cytosolic alpha-D-mannosidase.
    Grard T; Herman V; Saint-Pol A; Kmiecik D; Labiau O; Mir AM; Alonso C; Verbert A; Cacan R; Michalski JC
    Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):787-92. PubMed ID: 8670153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity of rat liver cytosolic alpha-D-mannosidase. Novel degradative pathway for oligomannosidic type glycans.
    Haeuw JF; Strecker G; Wieruszeski JM; Montreuil J; Michalski JC
    Eur J Biochem; 1991 Dec; 202(3):1257-68. PubMed ID: 1837268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital dyserythropoietic anemias.
    Marks PW; Mitus AJ
    Am J Hematol; 1996 Jan; 51(1):55-63. PubMed ID: 8571938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ricin-resistant mutants of baby-hamster-kidney cells deficient in alpha-mannosidase-II-catalyzed processing of asparagine-linked oligosaccharides.
    Hughes RC; Feeney J
    Eur J Biochem; 1986 Jul; 158(2):227-37. PubMed ID: 3732270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital disorders involving defective N-glycosylation of proteins.
    Schachter H
    Cell Mol Life Sci; 2001 Jul; 58(8):1085-104. PubMed ID: 11529501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mannosidase inhibitor blocking conversion of high mannose to complex oligosaccharides.
    Fuhrmann U; Bause E; Legler G; Ploegh H
    Nature; 1984 Feb 23-29; 307(5953):755-8. PubMed ID: 6230538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase.
    Fukuda MN; Masri KA; Dell A; Thonar EJ; Klier G; Lowenthal RM
    Blood; 1989 Apr; 73(5):1331-9. PubMed ID: 2495036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Congenital dyserythropoietic anemia type II (HEMPAS)].
    Fukuda MN
    Tanpakushitsu Kakusan Koso; 1992 Aug; 37(11 Suppl):1929-34. PubMed ID: 1410484
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolation and characterization of a class II alpha-mannosidase cDNA from lepidopteran insect cells.
    Jarvis DL; Bohlmeyer DA; Liao YF; Lomax KK; Merkle RK; Weinkauf C; Moremen KW
    Glycobiology; 1997 Feb; 7(1):113-27. PubMed ID: 9061370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential and mutually compensatory roles of {alpha}-mannosidase II and {alpha}-mannosidase IIx in N-glycan processing in vivo in mice.
    Akama TO; Nakagawa H; Wong NK; Sutton-Smith M; Dell A; Morris HR; Nakayama J; Nishimura S; Pai A; Moremen KW; Marth JD; Fukuda MN
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):8983-8. PubMed ID: 16754854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the Golgi-localized enzyme alpha-mannosidase IIx in Chinese hamster ovary cells results in the conversion of hexamannosyl-N-acetylchitobiose to tetramannosyl-N-acetylchitobiose in the N-glycan-processing pathway.
    Oh-Eda M; Nakagawa H; Akama TO; Lowitz K; Misago M; Moremen KW; Fukuda MN
    Eur J Biochem; 2001 Mar; 268(5):1280-8. PubMed ID: 11231279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation, characterization, and expression of cDNAs encoding murine alpha-mannosidase II, a Golgi enzyme that controls conversion of high mannose to complex N-glycans.
    Moremen KW; Robbins PW
    J Cell Biol; 1991 Dec; 115(6):1521-34. PubMed ID: 1757461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human lysosomal alpha(1----6)-mannosidase active on the branched trimannosyl core of complex glycans.
    Daniel PF; Evans JE; De Gasperi R; Winchester B; Warren CD
    Glycobiology; 1992 Aug; 2(4):327-36. PubMed ID: 1421754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEMPAS disease: genetic defect of glycosylation.
    Fukuda MN
    Glycobiology; 1990 Sep; 1(1):9-15. PubMed ID: 2136385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS).
    Denecke J; Kranz C; Nimtz M; Conradt HS; Brune T; Heimpel H; Marquardt T
    Glycoconj J; 2008 May; 25(4):375-82. PubMed ID: 18166993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.